Registro:

Referencias:

• Folkman, J., Tumor angiogenesis: Therapeutic implications (1971) N Engl J Med, 285, pp. 1182-1186
• Shekhar, M.P., Pauley, R., Heppner, G., Host microenvironment in breast cancer development: Extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast (2003) Breast Cancer Res, 5, pp. 130-135
• Cunha, G.R., Hayward, S.W., Wang, Y.Z., Ricke, W.A., Role of the stromal microenvironment in carcinogenesis of the prostate (2003) Int J Cancer, 107, pp. 1-10
• Sternlicht, M.D., Lochter, A., Sympson, C.J., Huey, B., Rougier, J.P., Gray, J.W., Pinkel, D., Werb, Z., The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis (1999) Cell, 98, pp. 137-146
• Tlsty, T.D., Hein, P.W., Know thy neighbor: Stromal cells can contribute oncogenic signals (2001) Curr Opin Genet Dev, 11, pp. 54-59
• Maffini, M.V., Soto, A.M., Calabro, J.M., Ucci, A.A., Sonnenschein, C., The stroma as a crucial target in rat mammary gland carcinogenesis (2004) J Cell Sci, 117, pp. 1495-1502
• Barcellos-Hoff, M.H., Ravani, S.A., Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells (2000) Cancer Res, 60, pp. 1254-1260
• Micke, P., Ostman, A., Exploring the tumour environment: Cancer-associated fibroblasts as targets in cancer therapy (2005) Expert Opin Ther Targets, 9, pp. 1217-1233
• Sappino, A.P., Skalli, O., Jackson, B., Schurch, W., Gabbiani, G., Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues (1988) Int J Cancer, 41, pp. 707-712
• Orimo, A., Weinberg, R.A., Stromal fibroblasts in cancer: A novel tumor-promoting cell type (2006) Cell Cycle, 5, pp. 1597-1601
• Orimo, A., Gupta, P.B., Sgroi, D.C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V.J., Weinberg, R.A., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion (2005) Cell, 121, pp. 335-348
• Zhang, H.Z., Bennett, J.M., Smith, K.T., Sunil, N., Haslam, S.Z., Estrogen mediates mammary epithelial cell proliferation in serum-free culture indirectly via mammary stroma-derived hepatocyte growth factor (2002) Endocrinology, 143, pp. 3427-3434
• Thomson, A.A., Role of androgens and fibroblast growth factors in prostatic development (2001) Reproduction, 121, pp. 187-195
• Lanari, C., Kordon, E., Molinolo, A., Pasqualini, C.D., Charreau, E.H., Mammary adenocarcinomas induced by medroxyprogesterone acetate: Hormone dependence and EGF receptors of BALB/c in vivo sublines (1989) Int J Cancer, 43, pp. 845-850
• Montecchia, M.F., Lamb, C., Molinolo, A.A., Luthy, I.A., Pazos, P., Charreau, E., Vanzulli, S., Lanari, C., Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas (1999) J Steroid Biochem Mol Biol, 68, pp. 11-21
• Lamb, C., Simian, M., Molinolo, A., Pazos, P., Lanari, C., Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: Progesterone receptor involvement in serum or growth factor-induced cell proliferation (1999) J Steroid Biochem Mol Biol, 70, pp. 133-142
• Lamb, C.A., Helguero, L.A., Giulianelli, S., Soldati, R., Vanzulli, S.I., Molinolo, A., Lanari, C., Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice (2005) Breast Cancer Res, 7, pp. R1111-R1121
• (1996) Guide for the care and use of laboratory animals, , Institute of Laboratory Animal Resources, Commission on Life Sciences National Research Council, Washington, D.C, National Academy Press
• Lanari, C., Luthy, I., Lamb, C.A., Fabris, V., Pagano, E., Helguero, L.A., Sanjuan, N., Molinolo, A.A., Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: In vivo and in vitro effects of estrogens and progestins (2001) Cancer Res, 61, pp. 293-302
• Dran, G., Luthy, I.A., Molinolo, A.A., Charreau, E.H., Pasqualini, C.D., Lanari, C., Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma (1995) Breast Cancer Res Treat, 35, pp. 173-186
• Fabris, V.T., Benavides, F., Conti, C., Merani, S., Lanari, C., Cytogenetic findings. Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model (2005) Cancer Genet Cytogenet, 161, pp. 130-139
• Sartorius, C.A., Groshong, S.D., Miller, L.A., Powell, R.L., Tung, L., Takimoto, G.S., Horwitz, K.B., New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: Only antiprogestin-occupied B- receptors are switched to transcriptional agonists by cAMP (1994) Cancer Res, 54, pp. 3868-3877
• St Bernard, R., Zheng, L., Liu, W., Winer, D., Asa, S.L., Ezzat, S., Fibroblast growth factor receptors as molecular targets in thyroid carcinoma (2005) Endocrinology, 146, pp. 1145-1153
• Vanzulli, S.I., Soldati, R., Meiss, R., Colombo, L., Molinolo, A.A., Lanari, C., Estrogen or antiprogestin treatment induces complete regression of pulmonary and axillary metastases in an experimental model of breast cancer progression (2005) Carcinogenesis, 26, pp. 1055-1063
• Mohammadi, M., Froum, S., Hamby, J.M., Schroeder, M.C., Panek, R.L., Lu, G.H., Eliseenkova, A.V., Hubbard, S.R., Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain (1998) EMBO J, 17, pp. 5896-5904
• Nakayama, T., Mutsuga, N., Tosato, G., Effect of fibroblast growth factor 2 on stromal cell-derived factor 1 production by bone marrow stromal cells and hematopoiesis (2007) J Natl Cancer Inst, 99, pp. 223-235
• Helguero, L.A., Viegas, M., Asaithamby, A., Shyamala, G., Lanari, C., Molinolo, A.A., Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment (2003) Breast Cancer Res Treat, 79, pp. 379-390
• Labriola, L., Salatino, M., Proietti, C.J., Pecci, A., Coso, O.A., Kornblihtt, A.R., Charreau, E.H., Elizalde, P.V., Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells (2003) Mol Cell Biol, 23, pp. 1095-1111
• Boonyaratanakornkit, V., McGowan, E., Sherman, L., Mancini, M.A., Cheskis, B.J., Edwards, D.P., The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle (2007) Mol Endocrinol, 21, pp. 359-375
• Simian, M., Molinolo, A., Lanari, C., Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression (2006) Am J Pathol, 168, pp. 270-279
• Clemm, D.L., Sherman, L., Boonyaratanakornkit, V., Schrader, W.T., Weigel, N.L., Edwards, D.P., Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody (2000) Mol Endocrinol, 14, pp. 52-65
• Pierson-Mullany, L.K., Lange, C.A., Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2 (2004) Mol Cell Biol, 24, pp. 10542-10557
• Shekhar, M.P., Santner, S., Carolin, K.A., Tait, L., Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity (2007) Am J Pathol, 170, pp. 1546-1560
• Shafie, S.M., Grantham, F.H., Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice (1981) J Natl Cancer Inst, 67, pp. 51-56
• Lamb, C.A., Fabris, V., Gorostiaga, M.A., Helguero, L.A., Efeyan, A., Bottino, M.C., Simian, M., Lanari, C., Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: A model for stromal parenchymal interactions (2005) J Cell Physiol, 202, pp. 672-682
• Sadlonova, A., Novak, Z., Johnson, M.R., Bowe, D.B., Gault, S.R., Page, G.P., Thottassery, J.V., Frost, A.R., Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture (2005) Breast Cancer Res, 7, pp. R46-R59
• Dailey, L., Ambrosetti, D., Mansukhani, A., Basilico, C., Mechanisms underlying differential responses to FGF signaling (2005) Cytokine Growth Factor Rev, 16, pp. 233-247
• Linder, C., Bystrom, P., Engel, G., Auer, G., Aspenblad, U., Strander, H., Linder, S., Correlation between basic fibroblast growth factor immunostaining of stromal cells and stromelysin-3 mRNA expression in human breast carcinoma (1998) Br J Cancer, 77, pp. 941-945
• Hunter, D.J., Kraft, P., Jacobs, K.B., Cox, D.G., Yeager, M., Hankinson, S.E., Wacholder, S., Yu, K., A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer (2007) Nat Genet, 39, pp. 870-874
• Schmahl, J., Kim, Y., Colvin, J.S., Ornitz, D.M., Capel, B., Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination (2004) Development, 131, pp. 3627-3636
• Prudovsky, I., Savion, N., Zhan, X., Friesel, R., Xu, J., Hou, J., McKeehan, W.L., Maciag, T., Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1 (1994) J Biol Chem, 269, pp. 31720-31724
• Marti, U., Ruchti, C., Kampf, J., Thomas, G.A., Williams, E.D., Peter, H.J., Gerber, H., Burgi, U., Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues (2001) Thyroid, 11, pp. 137-145
• Coleman-Krnacik, S., Rosen, J.M., Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development (1994) Mol Endocrinol, 8, pp. 218-229
• Chodosh, L.A., Gardner, H.P., Rajan, J.V., Stairs, D.B., Marquis, S.T., Leder, P.A., Protein kinase expression during murine mammary development (2000) Dev Biol, 219, pp. 259-276
• Jackson, D., Bresnick, J., Rosewell, I., Crafton, T., Poulsom, R., Stamp, G., Dickson, C., Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland (1997) J Cell Sci, 110 (PART 11), pp. 1261-1268
• Pal, M., Moffa, A., Sreekumar, A., Ethier, S.P., Barder, T.J., Chinnaiyan, A., Lubman, D.M., Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation (2006) Anal Chem, 78, pp. 702-710
• Qiu, M., Olsen, A., Faivre, E., Horwitz, K.B., Lange, C.A., Mitogen activated protein kinase regulates nuclear association of human progesterone receptors (2003) Mol Endocrinol, 17, pp. 628-642
• Su, G., Blaine, S.A., Qiao, D., Friedl, A., Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation (2007) J Biol Chem, 282, pp. 14906-14915
• Ross, R.K., Paganini-Hill, A., Wan, P.C., Pike, M.C., Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin (2000) J Natl Cancer Inst, 92, pp. 328-332
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial (2002) JAMA, 288, pp. 321-333. , Women's Health Initiative
• Aupperlee, M., Kariagina, A., Osuch, J., Haslam, S.Z., Progestins and breast cancer (2005) Breast Dis, 24, pp. 37-57
• Poole, A.J., Li, Y., Kim, Y., Lin, S.C., Lee, W.H., Lee, E.Y., Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist (2006) Science, 314, pp. 1467-1470

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------